JNJ submits long-acting Risperdal NDA

JNJ subsidiary Janssen Pharmaceutica Products (Titusville, N.J.) submitted an NDA to the FDA for its long-acting injectable formulation of the antipsychotic Risperdal risperidone. Long-acting Risperda...